Hospitals Probed Over Bid-Rigging
Federal prosecutors are investigating allegations that bid rigging and fraud at Mount Sinai Medical Center and New York-Presbyterian Hospital resulted in the hospitals awarding contracts worth tens of millions of dollars to outside contractors. online.wsj.com |
Trading Binary Bio Events: Amarin, ChemGenex, AstraZeneca
Mike Havrilla submits:Beyond the Bio Run-Up strategy of selecting a basket of small/micro-cap stocks with pending binary events such as FDA decisions and clinical trial results, another means of achieving diversification is by selecting a basket of companies with different types of pending catalysts. Below are some examples of how to categorize pending bio-catalyst events and some specific examples for each category. 1.) Long-Term Hold: Amarin Corp. (NASDAQ:AMRN) ($2.37, $234 million market cap)Complete Story » seekingalpha.com |
Gilead Sciences: Undervalued
Jason Chew submits: Gilead’s (GILD) stock has been in a funk. In the last three months, it has dropped 24% from about $46/share to about $35/share; this compares to a 15% drop for the Biotech HOLDERs index. It now has a PE of 11.1, lower than Pfizer (PFE), Novartis (NVS), and Sanofi Aventis (SNY), while having far higher growth and operating margins. Revenues soared 27% from 2008 to 2009 to $6.5 billion and are expected to grow another 15% in 2010 to about $7.4-$7.5 billion. Operating cash flow will be around a whopping $3 billion. It is an incredible money machine. Why is it selling at such a discount? Fist the bad news:Complete Story » seekingalpha.com |
Who are you calling obese? - Video
Anytime Fitness Launches Provocative Campaign, Challenging Parents to Lead the Way feedproxy.google.com |
Obama Dares Foes to Hobble Health Law
Obama promoted consumer-friendly provisions in health-care legislation passed six months ago, seeking to counter what the administration sees as a Republican-driven scare campaign. online.wsj.com |